Company Data
ProKidney Corp.
Ticker
PROK
Current Price
$1.5 -1.32%
Market Cap
$437.5M
Price Target
Refer to Report
Volume
320.8K
52wk Range
$1.34 - $4.44
Overview
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient’s own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.